2024 annual financial data
NovaBridge Biosciences 2024 Operating margin
NovaBridge Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -375,358,000 USD and net income was -162,257,000 USD.
Operating cash flow was -384,294,000 USD.
Get free NovaBridge Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -375,358,000 USD
- Net income
- -162,257,000 USD
- Operating cash flow
- -384,294,000 USD